Recurrent uterine serous carcinoma with a germline pathogenic BRCA2 variant treated using olaparib: A case report

A germline pathogenic variant in BRCA2 was secondarily found through genomic sequencing of uterine serous carcinoma. Clinical response to olaparib was observed in recurrent uterine serous carcinoma with a germline BRCA2 mutation. Here, we report, for the first time, a long-term clinical response to...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Kayo, Tsubamoto, Hiroshi, Ueda, Tomoko, Tajima, Chihiro, Nakagomi, Nami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152717/
https://www.ncbi.nlm.nih.gov/pubmed/32300630
http://dx.doi.org/10.1016/j.gore.2020.100563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152717/
https://www.ncbi.nlm.nih.gov/pubmed/32300630
http://dx.doi.org/10.1016/j.gore.2020.100563

Ejemplares similares